Cargando…
Enhancement of photodynamic therapy by mitomycin C: a preclinical and clinical study.
Photodynamic therapy (PDT) using Photofrin was used in combination with a hypoxic toxin (mitomycin C, MMC) to treat four patients with recurrent skin metastasis of a mammary carcinoma. In preclinical experiments an additive effect was found for the combination of MMC and PDT for treating subcutaneou...
Autores principales: | Baas, P., van Geel, I. P., Oppelaar, H., Meyer, M., Beynen, J. H., van Zandwijk, N., Stewart, F. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075831/ https://www.ncbi.nlm.nih.gov/pubmed/8611430 |
Ejemplares similares
-
Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.
por: van Geel, I. P., et al.
Publicado: (1995) -
Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy.
por: van Geel, I. P., et al.
Publicado: (1996) -
Foscan® uptake and tissue distribution in relation to photodynamic efficacy
por: Cramers, P, et al.
Publicado: (2003) -
Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.
por: Baas, P., et al.
Publicado: (1997) -
Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell line.
por: Datta, S. N., et al.
Publicado: (1997)